92 related articles for article (PubMed ID: 9058094)
1. Circulating intercellular adhesion molecule-1 in patients with lung cancer.
Taguchi O; Gabazza EC; Kobayashi T; Yoshida M; Yasui H; Kobayashi H
Intern Med; 1997 Jan; 36(1):14-8. PubMed ID: 9058094
[TBL] [Abstract][Full Text] [Related]
2. Circulating levels of soluble intercellular adhesion molecule-1 in non-small cell lung cancer patients.
De Vita F; Infusino S; Auriemma A; Orditura M; Catalano G
Oncol Rep; 1998; 5(2):393-6. PubMed ID: 9468565
[TBL] [Abstract][Full Text] [Related]
3. The relationship between the serum intercellular adhesion molecule-1 level and the prognosis of the disease in lung cancer.
Shin HS; Jung CH; Park HD; Lee SS
Korean J Intern Med; 2004 Mar; 19(1):48-52. PubMed ID: 15053044
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of soluble adhesion molecules CD44 (CD44st, CD44v5, CD44v6), ICAM-1, and VCAM-1 as tumor markers in head and neck cancer.
Kawano T; Yanoma S; Nakamura Y; Shiono O; Kokatu T; Kubota A; Furukawa M; Tsukuda M
Am J Otolaryngol; 2005; 26(5):308-13. PubMed ID: 16137528
[TBL] [Abstract][Full Text] [Related]
5. Soluble adhesion molecules E-cadherin, intercellular adhesion molecule-1, and E-selectin as lung cancer biomarkers.
Gogali A; Charalabopoulos K; Zampira I; Konstantinidis AK; Tachmazoglou F; Daskalopoulos G; Constantopoulos SH; Dalavanga Y
Chest; 2010 Nov; 138(5):1173-9. PubMed ID: 20495107
[TBL] [Abstract][Full Text] [Related]
6. [The immunomodulating role of indomethacin in the chemoradiation treatment of inoperable patients with lung cancer].
Kas'ianenko IV; Pivniuk VM; Lisitsa AM; Kovalenko NA; Bagirian MA
Vopr Onkol; 1992; 38(10):1183-7. PubMed ID: 1343143
[TBL] [Abstract][Full Text] [Related]
7. Serum levels of soluble intercellular adhesion molecule-1 (ICAM-1, CD54) in patients with non-small-cell lung cancer: correlation with histological expression of ICAM-1 and tumour stage.
Grothey A; Heistermann P; Philippou S; Voigtmann R
Br J Cancer; 1998 Mar; 77(5):801-7. PubMed ID: 9514061
[TBL] [Abstract][Full Text] [Related]
8. The value of serum Bcl-2 levels in advanced lung cancer patients.
Tas F; Duranyildiz D; Oguz H; Camlica H; Oral EN; Yasasever V; Topuz E
Med Oncol; 2005; 22(2):139-43. PubMed ID: 15965276
[TBL] [Abstract][Full Text] [Related]
9. Circulating intercellular adhesion molecule-1 (ICAM-1), vascular cell adhesion molecule-1 (VCAM-1) and E-selectin in urological malignancies.
Perabo F; Sharma S; Gierer R; Wirger A; Fimmers R; Steiner G; Adam M; Schultze-Seemann W
Indian J Cancer; 2001 Mar; 38(1):1-7. PubMed ID: 14758878
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of serum levels of E-selectin, intercellular adhesion molecule-1, and vascular cell adhesion molecule-1 in gastric cancer patients.
Alexiou D; Karayiannakis AJ; Syrigos KN; Zbar A; Sekara E; Michail P; Rosenberg T; Diamantis T
Am J Gastroenterol; 2003 Feb; 98(2):478-85. PubMed ID: 12591072
[TBL] [Abstract][Full Text] [Related]
11. Soluble ICAM-1 levels in small-cell lung cancer: prognostic value for survival and predictive significance for response during chemotherapy.
Kotteas EA; Gkiozos I; Tsagkouli S; Bastas A; Ntanos I; Saif MW; Syrigos KN
Med Oncol; 2013; 30(3):662. PubMed ID: 23884579
[TBL] [Abstract][Full Text] [Related]
12. [Study on serum levels of E- selectin, integrin beta 1 subunit and intercellular adhesion molecule-1 in gastric cancer patients and their clinical implications].
Shao QS; Ye ZY; Ling ZQ; Zhang W; Chen XR
Zhonghua Wei Chang Wai Ke Za Zhi; 2005 Mar; 8(2):155-8. PubMed ID: 16155830
[TBL] [Abstract][Full Text] [Related]
13. Clinical evaluation of serum concentrations of intercellular adhesion molecule-1 in patients with colorectal cancer.
Kang X; Wang F; Xie JD; Cao J; Xian PZ
World J Gastroenterol; 2005 Jul; 11(27):4250-3. PubMed ID: 16015700
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of the preoperative serum-soluble intercellular adhesion molecule-1 in non-small cell lung cancer.
Kamiyoshihara M; Kawashima O; Otani Y; Morishita Y
J Cardiovasc Surg (Torino); 2002 Oct; 43(5):729-34. PubMed ID: 12386593
[TBL] [Abstract][Full Text] [Related]
15. Increased serum levels of tumor necrosis factor-alpha are correlated to soluble intercellular adhesion molecule-1 concentrations in non-small cell lung cancer patients.
De Vita F; Orditura M; Infusino S; Auriemma A; Catalano G
Int J Mol Med; 1998 Mar; 1(3):605-8. PubMed ID: 9852272
[TBL] [Abstract][Full Text] [Related]
16. Serum P-selectin, soluble vascular cell adhesion molecule-I (s-VCAM-I) and soluble intercellular adhesion molecule-I (s-ICAM-I) levels in bladder carcinoma patients with different stages.
Coskun U; Sancak B; Sen I; Bukan N; Tufan MA; Gülbahar O; Sozen S
Int Immunopharmacol; 2006 Apr; 6(4):672-7. PubMed ID: 16504931
[TBL] [Abstract][Full Text] [Related]
17. A novel anticancer effect of thalidomide: inhibition of intercellular adhesion molecule-1-mediated cell invasion and metastasis through suppression of nuclear factor-kappaB.
Lin YC; Shun CT; Wu MS; Chen CC
Clin Cancer Res; 2006 Dec; 12(23):7165-73. PubMed ID: 17145842
[TBL] [Abstract][Full Text] [Related]
18. [The value of carcinoembryonic antigens in patients with advanced lung cancer: in relation to chemotherapy].
Shinkai T; Saijo N; Tominaga K; Eguchi K; Shimizu E; Takahashi K; Sasaki Y; Ohkura H
Gan To Kagaku Ryoho; 1984 May; 11(5):1056-63. PubMed ID: 6202246
[TBL] [Abstract][Full Text] [Related]
19. Serum activated leukocyte cell adhesion molecule and intercellular adhesion molecule-1 in patients with gastric cancer: Can they be used as biomarkers?
Erturk K; Tastekin D; Bilgin E; Serilmez M; Bozbey HU; Sakar B
Biomed Pharmacother; 2016 Feb; 77():86-91. PubMed ID: 26796270
[TBL] [Abstract][Full Text] [Related]
20. Soluble Human Leukocyte Antigen-G in the Bronchoalveolar Lavage of Lung Cancer Patients.
Montilla D; Pérez M; Borges L; Bianchi G; Cova JA
Arch Bronconeumol; 2016 Aug; 52(8):420-4. PubMed ID: 27004472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
